These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6611328)

  • 1. Analysis of monoclonal antibodies reactive with human class II beta chains by two-dimensional electrophoresis and Western blotting.
    Radka SF; Machamer CE; Cresswell P
    Hum Immunol; 1984 Jul; 10(3):177-86. PubMed ID: 6611328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SFR3-DR5, a monoclonal antibody with HLA-DR5 specificity.
    Radka SF; Machamer C; Cresswell P; Kostyu DD; Ward FE; Amos DB
    J Immunol; 1983 Apr; 130(4):1863-6. PubMed ID: 6187822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and functional evidence that an MT3 supertypic determinant defined by a monoclonal antibody is carried on the DR molecule on HLA-DR7 cell lines.
    Horibe K; Flomenberg N; Pollack MS; Adams TE; Dupont B; Knowles RW
    J Immunol; 1984 Dec; 133(6):3195-202. PubMed ID: 6208273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new supertypic HLA class II determinant (PL2) differentially expressed with DR7, DRw11(5), DRw13(w6), DRw14(w6), DR3, and DR2 and biochemically localized to DR7 molecules.
    Horibe K; Knowles RW; Dupont B
    Hum Immunol; 1986 May; 16(1):14-23. PubMed ID: 2423484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
    Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
    J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen.
    Shackelford DA; Mann DL; van Rood JJ; Ferrara GB; Strominger JL
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4566-70. PubMed ID: 6974868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A biochemical analysis of the secregation of HLA-DR heavy and light chains in a family studied by two-dimensional gel electrophoresis.
    Roux-Dosseto M; Rohner C; Birnbaum D; Bourgue F; Rebai N; Mawas C; Goridis C
    Ann Immunol (Paris); 1983; 134C(1):55-81. PubMed ID: 6407385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies to sheep MHC class II molecules recognize all HLA-D or subsets of HLA-D region products.
    Puri NK; de Kretser T; Brandon MR
    Hum Immunol; 1987 Nov; 20(3):195-207. PubMed ID: 3501780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological biochemical and functional characterisation of three different HLA-DR monoclonal antibodies derived from C57BL6 mice.
    Sachs JA; Fernandez N; Kurpisz M; Okoye R; Ogilvie J; Awad J; Labeta M; Festenstein H
    Tissue Antigens; 1986 Oct; 28(4):199-207. PubMed ID: 2949394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cells homozygous for two HLA-DR7-associated HLA-D specificities express highly similar DR molecules but different DQ molecules.
    Karr RW; Hsu SH; Bias WB
    Hum Immunol; 1986 Feb; 15(2):198-210. PubMed ID: 3081469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Ia molecules carrying MT1 determinants: purification with a monoclonal antibody.
    Falk JA; Lewis WH; Letarte M
    Hum Immunol; 1985 Aug; 13(4):265-80. PubMed ID: 2411699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis by sequential immunoprecipitations of the specificities of the monoclonal antibodies TU22,34,35,36,37,39,43,58 and YD1/63.HLK directed against human HLA class II antigens.
    Ziegler A; Heinig J; Müller C; Götz H; Thinnes FP; Uchańska-Ziegler B; Wernet P
    Immunobiology; 1986 Mar; 171(1-2):77-92. PubMed ID: 3486813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-dimensional gel analysis of the polypeptides precipitated by a polymorphic HLA-DR1,2,w6 monoclonal antibody: evidence for a third locus.
    De Kretser TA; Crumpton MJ; Bodmer JG; Bodmer WF
    Eur J Immunol; 1982 Jul; 12(7):600-6. PubMed ID: 6811289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An epitope common to HLA class I and class II antigens, Ig light chains, and beta 2-microglobulin.
    Lutz PM; Cresswell P
    Immunogenetics; 1987; 25(4):228-33. PubMed ID: 2437022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecules recognized by anti-MT2 alloantisera and anti-MT2-like (DRw52) monoclonal antibodies are different.
    Schiffenbauer J; Bono C; Schwartz BD
    Hum Immunol; 1985 Apr; 12(4):223-33. PubMed ID: 3872866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A monoclonal antibody recognizing HLA-DR2 on malignant and activated cells.
    Fuggle SV; Kirkley J; Ting A; Morris PJ
    Immunogenetics; 1983; 18(4):415-28. PubMed ID: 6195109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide map comparisons of similar serologically defined HLA-DR antigens isolated from different lymphoblastoid cell lines.
    Goyert SM; Gatti R; Silver J
    Hum Immunol; 1982 Nov; 5(3):205-14. PubMed ID: 6983516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity.
    Matsuyama T; Schwenzer J; Silver J; Winchester R
    J Immunol; 1986 Aug; 137(3):934-40. PubMed ID: 2424991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.